Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Payables (2020 - 2025)

Intelligent Bio Solutions has reported Payables over the past 5 years, most recently at $2.2 million for Q2 2024.

  • For Q2 2024, Payables fell 25.09% year-over-year to $2.2 million; the TTM value through Jun 2024 reached $2.2 million, down 25.09%, while the annual FY2024 figure was $2.2 million, 25.09% down from the prior year.
  • Payables for Q2 2024 was $2.2 million at Intelligent Bio Solutions, down from $2.5 million in the prior quarter.
  • Over five years, Payables peaked at $4.0 million in Q3 2023 and troughed at $448886.0 in Q4 2021.
  • A 5-year average of $1.7 million and a median of $1.6 million in 2021 define the central range for Payables.
  • On a YoY basis, Payables climbed as much as 430.02% in 2022 and fell as far as 41.9% in 2022.
  • Year by year, Payables stood at $734825.0 in 2020, then tumbled by 38.91% to $448886.0 in 2021, then surged by 430.02% to $2.4 million in 2022, then decreased by 10.32% to $2.1 million in 2023, then grew by 4.05% to $2.2 million in 2024.
  • Business Quant data shows Payables for INBS at $2.2 million in Q2 2024, $2.5 million in Q1 2024, and $2.1 million in Q4 2023.